Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Zhengye Biotechnology Holding Limited (ZYBT) stock profile

Zhengye Biotechnology Holding Limited researches, develops, manufactures, and sells veterinary vaccines for livestock in China. Its product offerings include vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company exports its products to Vietnam, Pakistan, and Egypt. Founded in 2004 and headquartered in Jilin, China, Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Key facts

SymbolZYBT
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOSonglin Song
Employees278
HeadquartersJilin, CN
IPO2025-01-07
Websitewww.jlzybio.com

Explore ZYBT on Vantafin

  • Zhengye Biotechnology Holding Limited Overview
  • Zhengye Biotechnology Holding Limited Financials
  • Zhengye Biotechnology Holding Limited News
  • Zhengye Biotechnology Holding Limited Events
  • Zhengye Biotechnology Holding Limited SEC filings

Frequently asked questions

What does Zhengye Biotechnology Holding Limited (ZYBT) do?
Zhengye Biotechnology Holding Limited researches, develops, manufactures, and sells veterinary vaccines for livestock in China. Its product offerings include vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company exports its products to Vietnam, Pakistan, and Egypt. Founded in 2004 and headquartered in Jilin, China, Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Where is ZYBT stock listed?
Zhengye Biotechnology Holding Limited trades under the ticker ZYBT on NASDAQ.
How can I research ZYBT's financials and filings?
Vantafin provides Zhengye Biotechnology Holding Limited's income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the ZYBT profile.